BMY EBITDA Margin

Bristol Myers Squibb · EBITDA Margin

BMY logo

BMY EBITDA Margin

Latest reported34.19%
BMY EBITDA Margin (21.54% → 34.19%)
High-resolution chart · PNG

BMY ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
31.6008%
6.559%
43.0298%
41.6409%
43.3718%
11.5927%
28.2157%
30.0873%
29.4378%
33.2733%
15.9239%
19.2141%
23.5154%
18.1772%
36.4997%
35.0185%
34.5225%
28.6547%
22.8447%
18.4939%
24.2932%
27.7245%
27.3859%
26.6902%
30.3043%
36.9565%
29.2602%
27.7893%
30.112%
29.6847%
29.5126%
29.6145%
23.7536%
20.2133%
26.9917%
25.5631%
13.9188%
22.8441%
21.5401%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.